In terms of market performance, Arcadia Biosciences Inc had a somewhat regular. The highest value for the stock in the past year was $5.34 on 12/05/24, while the lowest value was $1.85 on 04/15/24.
52-week price history of RKDA Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Arcadia Biosciences Inc’s current trading price is 35.77% away from its 52-week high, while its distance from the 52-week low is 291.64%. The stock’s price range during this period has fluctuated between $1.85 and $5.34. Shares of the company, which operates in the Consumer Defensive sector, recorded a trading volume of around 57.71 million for the day, which was evidently higher than the average daily volume of 14770.0 over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Arcadia Biosciences Inc (RKDA) has experienced a quarterly rise of 160.60% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.89M and boasts a workforce of 21 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.12, with a change in price of +4.99. Similarly, Arcadia Biosciences Inc recorded 547,877 in trading volume during the last 100 days, posting a change of +163.50%.
RKDA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for RKDA stands at 0.03. Similarly, the long-term debt-to-equity ratio is also 0.00.
RKDA Stock Stochastic Average
The raw stochastic average for Arcadia Biosciences Inc over the last 50 days is presently at 70.80%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 70.80%. Further, the company’s Stochastic %K and %D values for the last 20 days were 27.37% and 14.33%, respectively.
RKDA Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 131.63%.However, over the last six months, we can see a weaker performance of 149.35%. Over the last 30 days, the price of RKDA has fallen by 92.82%. And in the last five days, it has surged by 162.68%.
